Skip to main content
CBUS logo

CBUS · Cibus, Inc.

Track CBUS — free
$1.77 -0.13 (-6.84%) At close · Aug 14
Market Cap
$135.28M
Shares
76.43M

Cibus, Inc. Earnings Call Transcripts

Every quarterly earnings call for Cibus, Inc. (CBUS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-13
Cibus 2Q26 Financial Results Conference Call
Revenue
$994,000
▲ 6.5% YoY
Diluted EPS
$-0.29
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-14
Cibus, Inc. Q1 FY2026 Earnings Call
Confident tone Rice commercial launch (LATAM and U.S.) Sustainable ingredients / biofragrance Pipeline breadth (wheat, canola, other crops)
Revenue
$1.68M
▲ 62.6% YoY
Diluted EPS
$-0.33
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
Cibus, Inc. Q4 FY2025 Earnings Call
Confident tone Rice program and herbicide-tolerant traits Geographic expansion and key markets Commercialization model and royalty framework
Revenue
$1.06M*
▼ 12.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Cibus, Inc. Q3 FY2025 Earnings Call
Confident tone Rice herbicide tolerance commercialization Geographic expansion (India/Asia) Rapid Trait Development System (RTDS)
Revenue
$615,000
▼ 63.1% YoY
Diluted EPS
$-0.44
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Cibus, Inc. Q2 FY2025 Earnings Call
Confident tone Rice herbicide tolerance (HT1, HT3) Biofragrance / sustainable ingredients revenue Opportunity pipeline traits (productivity, quality)
Revenue
$933,000
▲ 11.3% YoY
Diluted EPS
$-0.61
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-21
Cibus, Inc. Q1 FY2025 Earnings Call
Confident tone Rice commercialization (HT traits) Disease resistance / sclerotinia (white mold) RTDS gene editing platform
Revenue
$1.03M
▲ 89.7% YoY
Diluted EPS
$-1.34
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Cibus, Inc. Q4 FY2024 Earnings Call
Revenue
$1.21M*
▲ 9.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Cibus, Inc. Q3 FY2024 Earnings Call
Confident tone Trait Machine process and speed Rice platform (HT1, HT3, stacked traits) Albaugh / RTDC agreement
Revenue
$1.67M
▲ 250.9% YoY
Diluted EPS
$-7.63
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Cibus, Inc. Q2 FY2024 Earnings Call
Confident tone Disease resistance (Sclerotinia) Herbicide tolerant traits in rice Crop platforms expansion (wheat, soybean)
Revenue
$838,000
▲ 325.4% YoY
Diluted EPS
$-1.14
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Cibus, Inc. Q1 FY2024 Earnings Call
Confident tone Rapid Trait Development System (RTDS) platform expansion HT2 trait potential across crops Regulatory progress for gene editing globally
Revenue
$545,000
▲ 1197.6% YoY
Diluted EPS
$-1.12
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-08
Cibus, Inc. Q4 FY2023 Earnings Call
Confident tone PSR Canola trait commercialization Herbicide tolerance rice traits Customer engagements and royalty potential
Revenue
$1.10M*
▲ 2526.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Cibus, Inc. Q3 FY2023 Earnings Call
Revenue
$475,000
▲ 1031% YoY
Diluted EPS
$-1.59
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Cibus, Inc. Q2 FY2023 Earnings Call
Revenue
$197,000
▲ 380.5% YoY
Diluted EPS
$-3.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q3
2022-11-03
Cibus, Inc. Q3 FY2022 Earnings Call
Revenue
$42,000
▼ 99.5% YoY
Diluted EPS
$-6.36
Gross margin
100.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Cibus, Inc. Q2 FY2022 Earnings Call
Revenue
$41,000
▼ 99.7% YoY
Diluted EPS
$-2.66
Gross margin
100.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Cibus, Inc. Q1 FY2022 Earnings Call
Revenue
$32,000
▼ 99.3% YoY
Diluted EPS
$-6.70
Gross margin
100.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Cibus, Inc. Q4 FY2021 Earnings Call
Revenue
$1.94M*
▼ 86% YoY
Gross margin
-3.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-05
Cibus, Inc. Q3 FY2021 Earnings Call
Revenue
$7.76M
▲ 48.1% YoY
Diluted EPS
$-10.00
Gross margin
-6.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Cibus, Inc. Q2 FY2021 Earnings Call
Revenue
$11.88M
▲ 415% YoY
Diluted EPS
$-6.50
Gross margin
3.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Cibus, Inc. Q1 FY2021 Earnings Call
Revenue
$4.40M
▲ 85.2% YoY
Gross margin
-53.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
Cibus, Inc. Q4 FY2020 Earnings Call
Revenue
$13.93M*
▲ 270% YoY
Gross margin
-35.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Cibus, Inc. Q3 FY2020 Earnings Call
Revenue
$5.24M
▲ 76.6% YoY
Gross margin
-34.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Cibus, Inc. Q2 FY2020 Earnings Call
Revenue
$2.31M
▲ 465.4% YoY
Gross margin
-130.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Cibus, Inc. Q1 FY2020 Earnings Call
Revenue
$2.38M
▲ 1414% YoY
Gross margin
-63.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Cibus, Inc. Q4 FY2019 Earnings Call
Revenue
$3.76M
▲ 188100% YoY
Gross margin
-43.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–25 of 25 earnings calls
Key facts CIK 1705843 CUSIP 17166A101 13F (30d) 71 filings 61 filers Visit website Investor relations